TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Indivior ( (INDV) ) is now available.
On November 14, 2025, Indivior PLC announced its plan to re-domicile from the U.K. to Delaware, a move that will be voted on by shareholders at an Extraordinary General Meeting on December 11, 2025. This strategic shift is aimed at establishing Indivior Pharmaceuticals, Inc. as the new holding company for the Indivior Group, potentially impacting its operational framework and market positioning.
The most recent analyst rating on (INDV) stock is a Buy with a $41.00 price target. To see the full list of analyst forecasts on Indivior stock, see the INDV Stock Forecast page.
Spark’s Take on INDV Stock
According to Spark, TipRanks’ AI Analyst, INDV is a Neutral.
Indivior’s overall stock score is driven by strong earnings call results and positive technical indicators, despite valuation concerns and financial stability issues. The company’s growth prospects and strategic initiatives are promising, but high leverage and overvaluation pose risks.
To see Spark’s full report on INDV stock, click here.
More about Indivior
Average Trading Volume: 2,207,808
Technical Sentiment Signal: Buy
Current Market Cap: $3.76B
For a thorough assessment of INDV stock, go to TipRanks’ Stock Analysis page.